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Review Paper 
Corresponding to the global status of cancer, the 
burden of cancer is increasing in Iran in recent 
decades (1, 2). Cancer is the third leading cause of 
death in Iran after coronary heart disease and 
accidents (3).  Recent studies indicate an age 
adjusted incidence of 165 per 100,000 men and 141 
per 100,000 women of all kinds of cancer in the 
population of Tehran. In terms of cancer risk and 
incidence, this population is a fairly representative 
population of the whole country (4). From 1996 to 
2000, a retrospective survey was carried out to 
ascertain the incidence of cancers in five provinces 
including Ardebil, Guilan, Mazandaran and Golestan 
in the north, and Kerman in the south of Iran. These 
provinces covered about 16 percent of the population 
of Iran in 1996. Available medical records of cancer 
patients in public/private hospitals and diagnostic/
treatment facilities as well as death certificates of 
these five provinces were collected. During this 
period, there were 28,022 new cancer cases (57% 
men; 42% women; 1% unknown sex).  
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The burden of cancer is increasing rapidly during the last decade and 
it is expected that it will rise intensely in the future because of 
anticipated increased life expectancy and modern lifestyle. One of 
the first steps to control cancer is to collect data in the framework of 
cancer registries as well as conducting research in various cancer 
related areas, which could be achieved through establishment of 
cancer research network in Iran. The other important issue is not  
follow the early detection and prevention protocols and along 
treatment procedures. Considering the fact that cancer is the third 
leading cause of death in Iran, it is required that health system should 
try to meet the demands related to the diagnosis, treatment and 
palliative care of cancer patients. This review addresses the current 
status of research, diagnosis and therapy related to cancer in Iran. 
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The mean age at diagnosis was 55 (median age 60). 
In terms of age-standardized rate (per 100,000), the 
most common cancers in men were stomach (22.5), 
esophagus (12.1), bladder (7.5), lung (6.5), colon/
rectum (6.2) and prostate (5.6). The leading female 
cancers were breast (13.3), stomach (9.3), esophagus 
(8.9), colon/rectum (6.0), leukemia (2.4) and 
cervical cancer (2.3). It was predicted that the annual 
number of new cases in year 2010 in Iran compared 
to 1996 increased 65% (95% in women; 46% in 
men) at least to 53,000 persons. Generally, the 
incidence of cancer in Iran was among lowest in the 
world. It is expected that it will rise dramatically in 
the future because of anticipated increase in life 
expectancy and westernized lifestyle. This increase 
in the number of new cases is a huge burden for the 
health care system (5).  
Without correction, cancer occurrence measures 
can be remarkably under-estimated. Therefore, 
measuring the actual incidence rate of cancer 
requires the use of appropriate epidemiological 
methods. Fallah M. and Kharazmi E. used a novel 
method to compensate under-ascertainment of 
cancer cases in the very elderly (aged >65) to 
calculate corrected Iran cancer incidence. The crude 
rate was 13.6% (men 18.7%; women 8.1%) under-
estimated. The under-enumeration was 18.9% for the 
age standardized rate (men 25.4%; women 11.8%). 
There were about 7,000 new cancer cases more than 
original report (by 58,000 new cancer cases) in 
2002. Accordingly, corrected incidence for the year 
2050 will be 26.1% higher (men 32.8%; 
women17.3%) than the original estimate (49,000 
more) (6).   
Cancer registry status: Cancer registry is an 
important tool for any successful cancer control 
program. Based on the report by Parkin et al (2002), 
there are only three countries around Iran including 
Oman, Kuwait and Pakistan that have population-
based cancer registry (7). Compulsory report of 
cancer cases as a bill, was passed by Iranian 
Parliament in 1984. This was a good basic action 
that led to microscopic verification of the majority of 
cancer cases in Iran. Established cancer registries in 
Iran are including Mazandaran, Tehran, Shiraz, 
Ardabil and Iranian National Cancer Registry. The 
registry strategy has undergone several 
modifications over the past decades. The obligation 
to notify the cancer registries of new cancer cases 
has been a legal requirement since 1994. While only 
18% of all estimated cancer cases were reported in 
the first reports, this rate increased to 81% in 2005 
following establishment of cancer registries. But 
reporting to the Ministry of Health Registry was far 
from complete (8) . 
 
Cancer Research Status 
A network of cancer researchers was established in 
1998 in order to develop better means of 
communication, resource sharing and effective 
research management as well as preventing 
inefficiency and wasting of resources available to 
cancer researchers and scientists in Iran. The overall 
assessment of this study indicated the top first five 
areas of research priorities on cancer including;  
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1) Cancer surveillance and registration as the first 
priority; 2) Exogenous factors related to the origin 
and cause of the cancer; 3) Surveillance - patient 
care and survivorship issues; 4) Issues of patient 
quality of life end-of-life care; and 5) Cost analyses 
and health care delivery of cancer services (9).  
 
Cancer Diagnosis 
Although, cancer patients access to the expert 
professionals as well as sufficient cancer detection 
facilities in Iran, but the delay in diagnosis is still an 
important issue (10). The delay time in diagnosing 
and treating different cancers in various studies is 
about 2 to 5 months (11).  
Delay in diagnosis affects the treatment and 
prognosis of cancer. Studies showed that delays 
related to the patients were longer than those related 
to the professionals (12, 13). Patient delay makes a 
critical contribution to late diagnosis and poor 
survival in cases of cancer. Delayed presentation of 
asymptomatic cancer is a public health issue in Iran, 
making a major contribution to low survival. Despite 
the importance of this problem, current knowledge is 
insufficient to inform interventions to shorten patient 
delay. Finding of a qualitative research on breast 
cancer revealed four main themes related to the 
delay in seeking medical help including:                   
1) attributing symptoms to the benign conditions; 2) 
conditional health behavior; 3) inhibiting emotional 
expression; and 4) barriers to access to health care 
systems (14). 
A meta-ethnography, which synthesized existing 
qualitative evidence in order to gain a new 
understanding of help seeking behavior in women 
with self-discovered breast cancer symptoms led to 
identification of eight repeated key concepts 
including: symptom detection, initial symptom 
interpretation, symptom monitoring, social 
interaction, emotional reaction, priority of medical 
help, appraisal of health services and personal-
environmental factors. Symptom interpretation was 
identified as the important step of the help seeking 
process, which changed across the process through 
active monitoring of symptoms, social interactions 
and emotional reactions. The perceived seriousness 
of the situation, priority to receive medical attention, 
perceived inaccessibility and unacceptability of the 
health care system influenced women's decision-
making about using health services. Educational 
programs aimed at correcting misunderstandings, 
erroneous social beliefs and improving self-
awareness could provide key strategies to improve 
health policy which would reduce patient delay (15).  
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Therapeutic and Care Issues 
 A correct cancer diagnosis is essential for adequate 
and effective treatment because every type of cancer 
requires a specific treatment regimen which 
encompasses one or more modalities such as 
surgery, and/or radiotherapy, and/or chemotherapy. 
These modalities are provided in the world-class 
cancer treatment in Iran (16-18). In recent decades, 
there was an excellent progress regarding cancer 
care and treatment in Iran. But, we need to have 
access to more advanced techniques and methods 
including Molecular Medicine, Nanomedicine, and 
non-invasive therapeutic procedures. Studies showed 
that using complementary and alternative medicine 
among Iranian cancer patients is unpopular (19). The 
primary goal of the therapeutic procedures is to cure 
cancer. Improving the patient's quality of life is also 
an important goal which is seriously placed on the 
agenda of cancer care. It can be achieved by 
supportive or palliative care and psychological 
support (20, 21).  
Conclusion 
The evidence suggests an increased prevalence of cancer in Iran. Despite significant progress in the 
diagnosis methods and treatment procedures of cancer in Iran, we still need a comprehensive strategic plan 
to manage all aspects of the relevant cancer care services. According to the national upstream health 
documents and strategies, it is possible to control the cancer tsunami, by focusing on improvement the 
public life style. 
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